TARGET AUDIENCE
The target audience for this educational series will be radiologists who are responsible for the diagnosis and ongoing surveillance of patients with bronchiectasis.

PROGRAM OVERVIEW
This activity is part of a national series that provides participants with education related to bronchiectasis. It is specifically intended to help address ongoing professional practice gaps and educational needs concerning the diagnosis and ongoing surveillance of patients with bronchiectasis.

Upon completion of this activity, the learners should be able to:

• Confirm the presence of bronchiectasis via high-resolution computed tomography (HRCT)
• Determine how radiologic imaging can help influence the etiology and treatment course for bronchiectasis
• Summarize the needs for subsequent radiologic surveillance of patients who are diagnosed with bronchiectasis

FACULTY
Mary M. Salvatore, MD
Diagnostic Radiologist
Jacobi Medical Center
New York, NY

Ashley Losier, MD
Pulmonologist and Critical Care Specialist
Yale University
New Haven, CT

PLANNING COMMITTEE
Mary M. Salvatore, MD
Diagnostic Radiologist
Jacobi Medical Center
New York, NY

Ashley Losier, MD
Pulmonologist and Critical Care Specialist
Yale University
New Haven, CT

ACCREDITATION STATEMENT

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

CREDIT DESIGNATION

Physicians: The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires individuals in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion.

Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an Educational Grant from Insmed.

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.